New rare variant associations with distinct phenotypes in patients with pulmonary arterial hypertension revealed with Bayesian inference.

E. Swietlik (Cambridge, United Kingdom), K. Lutz (Cincinnati , United States of America), D. Greene (Cambridge, United Kingdom), M. Pauciulo (Cincinnati , United States of America), T. Tilly (Cambridge, United Kingdom), D. Pandya (Cambridge, United Kingdom), N. Zhu (New York, United States of America), M. Cogliano (Sheffield , United Kingdom), C. Welch (New York, United States of America), A. Coleman (New York, United States of America), . Bioresource Rare Diseases Consortium (Cambridge, United Kingdom), Y. Shen (New York, United States of America), A. Swift (Sheffield , United Kingdom), W. Chung (New York, United States of America), W. Nichols (Cincinnati , United States of America), N. Morrell (Cambridge, United Kingdom), S. Graf (Cambridge, United Kingdom)

Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Session: Genetics and genomics of pulmonary arterial hypertension
Session type: Oral Presentation
Number: 4459
Disease area: Pulmonary vascular diseases

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Swietlik (Cambridge, United Kingdom), K. Lutz (Cincinnati , United States of America), D. Greene (Cambridge, United Kingdom), M. Pauciulo (Cincinnati , United States of America), T. Tilly (Cambridge, United Kingdom), D. Pandya (Cambridge, United Kingdom), N. Zhu (New York, United States of America), M. Cogliano (Sheffield , United Kingdom), C. Welch (New York, United States of America), A. Coleman (New York, United States of America), . Bioresource Rare Diseases Consortium (Cambridge, United Kingdom), Y. Shen (New York, United States of America), A. Swift (Sheffield , United Kingdom), W. Chung (New York, United States of America), W. Nichols (Cincinnati , United States of America), N. Morrell (Cambridge, United Kingdom), S. Graf (Cambridge, United Kingdom). New rare variant associations with distinct phenotypes in patients with pulmonary arterial hypertension revealed with Bayesian inference.. 4459

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Late Breaking Abstract - Convergence of clinical and computational phenotypes for rare variant association study (RVAS) in pulmonary arterial hypertension
Source: Virtual Congress 2021 – All about pulmonary arterial hypertension
Year: 2021



Genetic findings in patients with different forms of pulmonary hypertension
Source: Virtual Congress 2020 – Genetics and genomics of pulmonary arterial hypertension
Year: 2020




A new molecular genetic diagnostic approach for pulmonary arterial hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016

Comparative analysis of the plasma metabolomics in rodent models of pulmonary hypertension and patients with IPAH shows different metabolic signatures
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019

Molecular genetics and clinical features of Chinese idiopathic and heritable pulmonary arterial hypertension patients
Source: Eur Respir J 2012; 39: 597-603
Year: 2012



Risk stratification in pulmonary arterial hypertension using Bayesian analysis
Source: Eur Respir J, 56 (2) 2000008; 10.1183/13993003.00008-2020
Year: 2020



Contribution of thrombophilic genetic factors in development and recurrent manifestation of pulmonary embolism in young patients
Source: Annual Congress 2005 - News about pulmonary embolism
Year: 2005


Evidence for shared genetic risk factors between lymphangioleiomyomatosis and pulmonary function
Source: ERJ Open Res, 8 (1) 00375-2021; 10.1183/23120541.00375-2021
Year: 2022



Severe pulmonary hypertension after the discovery of the familial primary pulmonary hypertension gene
Source: Eur Respir J 2001; 17: 1065-1069
Year: 2001


Integrating haemodynamics identifies an extreme pulmonary hypertension phenotype
Source: Eur Respir J, 58 (2) 2004625; 10.1183/13993003.04625-2020
Year: 2021



Is pulmonary arterial hypertension associated with interferon-ß therapy for multiple sclerosis reversible? A case study to explore the complexity
Source: ERJ Open Res, 6 (1) 00328-2019; 10.1183/23120541.00328-2019
Year: 2020



Asthma and pulmonary arterial hypertension: Two phenotypes sharing a key underlying mechanism
Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases
Year: 2010


First identification of Krüppel-like factor 2 mutation in heritable pulmonary arterial hypertension
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017


Association of clinical features with HLA in chronic pulmonary thromboembolism
Source: Eur Respir J 2005; 25: 131-138
Year: 2005



Candidate genes for COPD in two large data sets
Source: Eur Respir J 2011; 37: 255
Year: 2011



Towards an understanding of pulmonary arterial hypertension (PAH): gene regulation patterns in pulmonary arterial resistance vessels of patients with PAH
Source: Eur Respir J 2006; 28: Suppl. 50, 526s
Year: 2006

Association of clusters of pulmonary function data with SNP polymorphisms in sarcoidosis patients
Source: Annual Congress 2008 - Sarcoidosis: pathophysiology and severity
Year: 2008


A novel murine model of severe pulmonary arterial hypertension
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010


Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Early risk prediction in idiopathic versus connective tissue disease-associated pulmonary arterial hypertension: call for a refined assessment
Source: ERJ Open Res, 7 (3) 00854-2020; 10.1183/23120541.00854-2020
Year: 2021